JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
PG&E
PCG
$39B
| $772K | ﹤0.01% |
71,029
+53,297
| +301% | +$457K |
|
3852
Applied Optoelectronics
AAOI
$11.7B
| $770K | ﹤0.01% |
64,905
-265,616
| -80% | -$2.83M |
|
3853
CALL
Amplify Junior Silver Miners ETF
SILJ
$3.88B
| $770K | ﹤0.01% |
+45,000
| New | +$472K |
|
3854
Puma Biotechnology
PBYI
$461M
| $769K | ﹤0.01% |
87,908
-4,402
| -5% | -$36.4K |
|
3855
AtriCure
ATRC
$2.23B
| $768K | ﹤0.01% |
23,619
+11,453
| +94% | +$326K |
|
3856
Xenon Pharmaceuticals
XENE
$6.19B
| $768K | ﹤0.01% |
58,593
+37,461
| +177% | +$394K |
|
3857
CEVA Inc
CEVA
$878M
| $766K | ﹤0.01% |
28,414
-276
| -1% | -$7.54K |
|
3858
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.15B
| $766K | ﹤0.01% |
4,395
+517
| +13% | +$74.6K |
|
3859
PUT
Philip Morris
PM
$296B
| $766K | ﹤0.01% |
9,000
| – | – |
|
3860
Nathan's Famous
NATH
$397M
| $765K | ﹤0.01% |
10,803
+6,321
| +141% | +$466K |
|
|
LNW
3861
PUT
DELISTED
Light & Wonder
LNW
| $763K | ﹤0.01% |
+28,500
| New | +$734K |
|
3862
Home Bancorp
HBCP
$572M
| $757K | ﹤0.01% |
19,316
+14,137
| +273% | +$549K |
|
3863
Mueller Water Products
MWA
$4.05B
| $757K | ﹤0.01% |
63,199
+2,366
| +4% | +$27K |
|
3864
Workiva
WK
$3.7B
| $757K | ﹤0.01% |
17,996
+1,360
| +8% | +$57.3K |
|
3865
Kratos Defense & Security Solutions
KTOS
$11.7B
| $755K | ﹤0.01% |
41,941
+12,218
| +41% | +$227K |
|
|
TNAV
3866
DELISTED
Telenav Inc.
TNAV
| $755K | ﹤0.01% |
155,287
-13,800
| -8% | -$67.2K |
|
|
ECOLW
3867
DELISTED
US Ecology, Inc. Warrant
ECOLW
| – | – |
0
| – | – |
|
3868
Northwest Bancshares
NWBI
$2.32B
| $753K | ﹤0.01% |
45,295
-246,263
| -84% | -$4.12M |
|
3869
Aaon
AAON
$7.42B
| $752K | ﹤0.01% |
22,811
+2,613
| +13% | +$84.7K |
|
3870
NextCure
NXTC
$38.4M
| $752K | ﹤0.01% |
1,112
+1,030
| +1,256% | +$517K |
|
3871
Intrepid Potash
IPI
$487M
| $751K | ﹤0.01% |
27,699
+6,777
| +32% | +$184K |
|
|
WMC
3872
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $751K | ﹤0.01% |
7,275
+4,475
| +160% | +$454K |
|
3873
Global X MSCI Argentina ETF
ARGT
$804M
| $745K | ﹤0.01% |
28,023
+7,443
| +36% | +$174K |
|
|
SWI
3874
DELISTED
SolarWinds Corporation Common Stock
SWI
| $745K | ﹤0.01% |
38,075
-19,363
| -34% | -$384K |
|
3875
Dianthus Therapeutics
DNTH
$6.21B
| $743K | ﹤0.01% |
3,065
+2,671
| +678% | +$499K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.